ConductScience.org, home

Paper39743545

The guided fire from within: intratumoral administration of mRNA-based vaccines to mobilize memory immunity and direct immune responses against pathogen to target solid tumors.

Li R and 13 others. Cell Discov, 2025. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. The guided fire from within: intratumoral administration of mRNA-based vaccines to mobilize memory immunity and direct immune responses against pathogen to target solid tumors. Papers, record 39743545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39743545

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The guided fire from within: intratumoral administration of mRNA-based vaccines to mobilize memory immunity and direct immune responses against pathogen to target solid tumors.
PubMed
Journal
Cell Discov
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
2.38, provisional
iCite
Revised in PubMed
2026-09-24
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li RRenhao
2Hu JCJing-Chuhttps://orcid.org/0000-0001-6144-7226
3Rong LLi
4He YYige
5Wang XXiaolei
6Lin XXuansheng
7Li WWenjun
8Wu YYangfan
9Kuwentrai CChaiyaporn
10Su CCanhui
11Yau TThomas
12Hung IFIvan Fan-Ngai
13Gao XXiang
14Huang JDJian-Donghttps://orcid.org/0000-0001-7531-2816

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120498667Cross-priming in health and disease.Nat Rev Immunol2010https://conductscience.org/library/papers/20498667PubMed
236604431Neoantigens: promising targets for cancer therapy.Signal Transduct Target Ther2023https://conductscience.org/library/papers/36604431PubMed
311231627Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.Nat Med2001https://conductscience.org/library/papers/11231627PubMed
419132916T cell activation.Annu Rev Immunol2009https://conductscience.org/library/papers/19132916PubMed
530089911Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.Nature2018https://conductscience.org/library/papers/30089911PubMed
628775780Treatment of Neuroblastoma with an Engineered "Obligate" Anaerobic Salmonella typhimurium Strain YB1.J Cancer2017https://conductscience.org/library/papers/28775780PubMed
722666539Explicit hypoxia targeting with tumor suppression by creating an "obligate" anaerobic Salmonella Typhimurium strain.Sci Rep2012https://conductscience.org/library/papers/22666539PubMed
823890059Oncology meets immunology: the cancer-immunity cycle.Immunity2013https://conductscience.org/library/papers/23890059PubMed
928263959Salmon provides fast and bias-aware quantification of transcript expression.Nat Methods2017https://conductscience.org/library/papers/28263959PubMed
1029141660xCell: digitally portraying the tissue cellular heterogeneity landscape.Genome Biol2017https://conductscience.org/library/papers/29141660PubMed
1135603308Advances in oncolytic virotherapy.Commun Med (Lond)2022https://conductscience.org/library/papers/35603308PubMed
128917636Direct transfer of a foreign MHC gene into human melanoma alters T cell receptor V beta usage by tumor-infiltrating lymphocytes.Cancer Immunol Immunother1996https://conductscience.org/library/papers/8917636PubMed
1330413827Cytokines in clinical cancer immunotherapy.Br J Cancer2019https://conductscience.org/library/papers/30413827PubMed
148506311Immunotherapy of malignancy by in vivo gene transfer into tumors.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8506311PubMed
1522781695Oncolytic virotherapy.Nat Biotechnol2012https://conductscience.org/library/papers/22781695PubMed
1638278784Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice.Nat Commun2024https://conductscience.org/library/papers/38278784PubMed
1735835409Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy.Cancer Lett2022https://conductscience.org/library/papers/35835409PubMed
1835401745Understanding of Immune Escape Mechanisms and Advances in Cancer Immunotherapy.J Oncol2022https://conductscience.org/library/papers/35401745PubMed
1934557778clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.Innovation (Camb)2021https://conductscience.org/library/papers/34557778PubMed
2022658128Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.N Engl J Med2012https://conductscience.org/library/papers/22658128PubMed

See all 58 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42844249Bioengineering strategies for improving the immunogenicity of mRNA vaccines.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42844249PubMed
42783445COVID-19 mRNA Vaccines as Antigen-Agnostic Immunomodulators: A Repurposing Perspective.Med Sci (Basel)2026https://conductscience.org/library/papers/42783445PubMed
42198337Delivery of mRNA Therapeutics Beyond Infectious Diseases: Design Innovations and Applications in Oncology, Cardiovascular, and Rare Genetic Diseases.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42198337PubMed
42087213Personalized immunotherapy in HCC: synthesis, delivery, and clinical progress of mRNA-based vaccines.Cancer Cell Int2026https://conductscience.org/library/papers/42087213PubMed
42071000Harnessing pre-existing measles immunity: mRNA-Lipid nanoparticle-mediated measles hemagglutinin expression boosts antitumor CD8⁺ T cell responses.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42071000PubMed
41180766EnteroMix and the emerging role of MRNA-based therapeutics in colorectal cancer: from preclinical tumor regression to clinical translation.Ann Med Surg (Lond)2025https://conductscience.org/library/papers/41180766PubMed
41002441Next-Generation mRNA Vaccines in Melanoma: Advances in Delivery and Combination Strategies.Cells2025https://conductscience.org/library/papers/41002441PubMed
40563598Periodic Boosters of COVID-19 Vaccines Do Not Affect the Safety and Efficacy of Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: A Longitudinal Analysis of the Vax-On-Third Study.Cancers (Basel)2025https://conductscience.org/library/papers/40563598PubMed
40282336The Bright Future of mRNA as a Therapeutic Molecule.Genes (Basel)2025https://conductscience.org/library/papers/40282336PubMed
40269562The treatment of breast cancer in the era of precision medicine.Cancer Biol Med2025https://conductscience.org/library/papers/40269562PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39743545

GET https://conductscience.org/api/papers/v1/39743545/references?page=2